XIFAXAN

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 65649-301
  • Package NDC 65649-301-03
  • Application number NDA021361
  • SPL ID b2e9bb84-e97e-4e7e-8a23-425418b4374d
  • SPL set ID c5e8e2fd-7087-4b78-9181-cc259c0be2f1
  • UNII L36O5T016N
  • RxCUI 429662
  • RxCUI 539789
  • RxCUI 856664
  • RxCUI 856666

What the source publishes

Labeler
Salix Pharmaceuticals, Inc.
Active ingredients
rifaximin
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:65649-301_b2e9bb84-e97e-4e7e-8a23-425418b4374d
{
  "name": "XIFAXAN",
  "splId": "b2e9bb84-e97e-4e7e-8a23-425418b4374d",
  "labels": [
    {
      "setId": "c5e8e2fd-7087-4b78-9181-cc259c0be2f1",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c5e8e2fd-7087-4b78-9181-cc259c0be2f1",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c5e8e2fd-7087-4b78-9181-cc259c0be2f1"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Salix Pharmaceuticals, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET in 1 BOTTLE (65649-301-03)",
      "package_ndc": "65649-301-03",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20040725"
    }
  ],
  "productId": "65649-301_b2e9bb84-e97e-4e7e-8a23-425418b4374d",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "65649-301",
  "deaSchedule": null,
  "genericName": "rifaximin",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "RIFAXIMIN",
      "strength": "200 mg/1"
    }
  ],
  "applicationNumber": "NDA021361",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20040725",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175500",
      "M0019113"
    ],
    "unii": [
      "L36O5T016N"
    ],
    "rxcui": [
      "429662",
      "539789",
      "856664",
      "856666"
    ],
    "spl_set_id": [
      "c5e8e2fd-7087-4b78-9181-cc259c0be2f1"
    ],
    "pharm_class_cs": [
      "Rifamycins [CS]"
    ],
    "pharm_class_epc": [
      "Rifamycin Antibacterial [EPC]"
    ],
    "manufacturer_name": [
      "Salix Pharmaceuticals, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:65649-301_b2e9bb84-e97e-4e7e-8a23-425418b4374d"